The Department of Defense Neurofibromatosis Research Program (NFRP) offers this Clinical Trial Award to advance understanding, diagnosis, and treatment of Neurofibromatosis (NF) and Schwannomatosis, aiming to eradicate their clinical impact. This grant supports clinical trials with the potential for major impact on treatment or management. A clinical trial is defined as prospective accrual of human subjects, testing interventions (e.g., device, drug, biologic, surgical procedure, behavioral intervention) for measurable outcomes (exploratory, safety, effectiveness, or efficacy) that directly affect the human subject. Funds are strictly for clinical trials, excluding preclinical research.
Opportunity ID: 91293
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-11-NFRP-CTA |
| Funding Opportunity Title: | DOD FY11 Neurofibromatosis Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 03, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 15, 2011 |
| Current Closing Date for Applications: | Sep 15, 2011 |
| Archive Date: | Oct 15, 2011 |
| Estimated Total Program Funding: | $2,800,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The Neurofibromatosis Research Program (NFRP) was established in 1996 to promote the understanding, diagnosis, and treatment of neurofibromatosis (NF). The vision of the FY11 NFRP is to find and fund the best research to eradicate the clinical impact of NF. The NFRP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of NF or Schwannomatosis. Funding from this award mechanism must support a clinical trial and cannot be used for preclinical research studies. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP and eReceipt HELP: 301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 91293 Full Announcement-1 -> fy11_nfrp cta pa_gg.pdf
Packages
| Agency Contact Information: | PA HELP and eReceipt HELP: 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00051411 | May 03, 2011 | Sep 15, 2011 | View |
Package 1
Mandatory forms
91293 RR_SF424_1_2-1.2.pdf
91293 PerformanceSite_1_4-1.4.pdf
91293 RR_Budget-1.1.pdf
91293 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
91293 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
